Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01219673 · BASELINE

Baseline characteristics

Symptom Burden in Head and Neck Cancer · Source last updated 2015-02-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      0
    2. group Id
      BG001
      value
      0
    3. group Id
      BG002
      value
      1
    4. group Id
      BG003
      value
      0
    5. group Id
      BG004
      value
      0
    6. group Id
      BG005
      value
      0
    7. group Id
      BG006
      value
      0
    8. group Id
      BG007
      value
      0
    9. group Id
      BG008
      value
      1
    units
    Participants
groups
  1. description
    Placebo by mouth 2 times every day. Placebo: 1 by mouth twice a day.
    id
    BG000
    title
    Placebo
  2. description
    Armodafinil 150 mg by mouth once a day. Armodafinil: 150 mg by mouth once a day.
    id
    BG001
    title
    Armodafinil
  3. description
    Minocycline 100 mg by muth two times a day. Minocycline: 100 mg by mouth twice a day.
    id
    BG002
    title
    Minocycline
  4. description
    Bupropion 100 mg by mouth two times a day. Bupropion: 100 mg by mouth twice a day.
    id
    BG003
    title
    Bupropion
  5. description
    Armodafinil 150 mg by mouth once a day. Minocycline 100 mg by mouth two times a day. Armodafinil: 150 mg by mouth once a day. Minocycline: 100 mg by mouth twice a day.
    id
    BG004
    title
    Armodafinil + Minocycline
  6. description
    Armodafinil 150 mg by mouth once a day. Bupropion 100 mg by mouth two times a day. Armodafinil: 150 mg by mouth once a day. Bupropion: 100 mg by mouth twice a day.
    id
    BG005
    title
    Armodafinil + Bupropion
  7. description
    Minocycline 100 mg by muth two times a day. Bupropion 100 mg by mouth two times a day. Minocycline: 100 mg by mouth twice a day. Bupropion: 100 mg by mouth twice a day.
    id
    BG006
    title
    Minocycline + Bupropion
  8. description
    Armodafinil 150 mg by mouth once a day. Minocycline 100 mg by muth two times a day. Bupropion 100 mg by mouth two times a day. Armodafinil: 150 mg by mouth once a day. Minocycline: 100 mg by mouth twice a day. Bupropion: 100 mg by mouth twice a day.
    id
    BG007
    title
    Armodafinil + Minocycline + Bupropion
  9. description
    Total of all reporting groups
    id
    BG008
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG002
          value
          0
        2. group Id
          BG008
          value
          0
      title
      <=18 years
    2. categories
      1. measurements
        1. group Id
          BG002
          value
          1
        2. group Id
          BG008
          value
          1
      title
      Between 18 and 65 years
    3. categories
      1. measurements
        1. group Id
          BG002
          value
          0
        2. group Id
          BG008
          value
          0
      title
      >=65 years
    param Type
    NUMBER
    title
    Age, Categorical
    unit Of Measure
    participants
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG002
          value
          0
        2. group Id
          BG008
          value
          0
      title
      Female
    2. categories
      1. measurements
        1. group Id
          BG002
          value
          1
        2. group Id
          BG008
          value
          1
      title
      Male
    param Type
    NUMBER
    title
    Gender
    unit Of Measure
    participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG002
          value
          1
        2. group Id
          BG008
          value
          1
      title
      United States
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants
population Description
Study halted due to low enrollment (one participant). No analysis completed.
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      0
    2. group Id
      BG001
      value
      0
    3. group Id
      BG002
      value
      1
    4. group Id
      BG003
      value
      0
    5. group Id
      BG004
      value
      0
    6. group Id
      BG005
      value
      0
    7. group Id
      BG006
      value
      0
    8. group Id
      BG007
      value
      0
    9. group Id
      BG008
      value
      1
    units
    Participants
groups
  1. description
    Placebo by mouth 2 times every day. Placebo: 1 by mouth twice a day.
    id
    BG000
    title
    Placebo
  2. description
    Armodafinil 150 mg by mouth once a day. Armodafinil: 150 mg by mouth once a day.
    id
    BG001
    title
    Armodafinil
  3. description
    Minocycline 100 mg by muth two times a day. Minocycline: 100 mg by mouth twice a day.
    id
    BG002
    title
    Minocycline
  4. description
    Bupropion 100 mg by mouth two times a day. Bupropion: 100 mg by mouth twice a day.
    id
    BG003
    title
    Bupropion
  5. description
    Armodafinil 150 mg by mouth once a day. Minocycline 100 mg by mouth two times a day. Armodafinil: 150 mg by mouth once a day. Minocycline: 100 mg by mouth twice a day.
    id
    BG004
    title
    Armodafinil + Minocycline
  6. description
    Armodafinil 150 mg by mouth once a day. Bupropion 100 mg by mouth two times a day. Armodafinil: 150 mg by mouth once a day. Bupropion: 100 mg by mouth twice a day.
    id
    BG005
    title
    Armodafinil + Bupropion
  7. description
    Minocycline 100 mg by muth two times a day. Bupropion 100 mg by mouth two times a day. Minocycline: 100 mg by mouth twice a day. Bupropion: 100 mg by mouth twice a day.
    id
    BG006
    title
    Minocycline + Bupropion
  8. description
    Armodafinil 150 mg by mouth once a day. Minocycline 100 mg by muth two times a day. Bupropion 100 mg by mouth two times a day. Armodafinil: 150 mg by mouth once a day. Minocycline: 100 mg by mouth twice a day. Bupropion: 100 mg by mouth twice a day.
    id
    BG007
    title
    Armodafinil + Minocycline + Bupropion
  9. description
    Total of all reporting groups
    id
    BG008
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG002
          value
          0
        2. group Id
          BG008
          value
          0
      title
      <=18 years
    2. categories
      1. measurements
        1. group Id
          BG002
          value
          1
        2. group Id
          BG008
          value
          1
      title
      Between 18 and 65 years
    3. categories
      1. measurements
        1. group Id
          BG002
          value
          0
        2. group Id
          BG008
          value
          0
      title
      >=65 years
    param Type
    NUMBER
    title
    Age, Categorical
    unit Of Measure
    participants
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG002
          value
          0
        2. group Id
          BG008
          value
          0
      title
      Female
    2. categories
      1. measurements
        1. group Id
          BG002
          value
          1
        2. group Id
          BG008
          value
          1
      title
      Male
    param Type
    NUMBER
    title
    Gender
    unit Of Measure
    participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG002
          value
          1
        2. group Id
          BG008
          value
          1
      title
      United States
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants
population Description
Study halted due to low enrollment (one participant). No analysis completed.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice